AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
A PHASE-II STUDY OF 5-AZA-2'DEOXYCYTIDINE (DECITABINE) IN HORMONE-INDEPENDENT METASTATIC (D2) PROSTATE-CANCER
Authors: THIBAULT A FIGG WD BERGAN RC LUSH RM MYERS CE TOMPKINS A REED E SAMID D
Citation: A. Thibault et al., A PHASE-II STUDY OF 5-AZA-2'DEOXYCYTIDINE (DECITABINE) IN HORMONE-INDEPENDENT METASTATIC (D2) PROSTATE-CANCER, Tumori, 84(1), 1998, pp. 87-89
IMPACT OF THE PUTATIVE DIFFERENTIATING AGENTS SODIUM PHENYLBUTYRATE AND SODIUM PHENYLACETATE ON PROLIFERATION, DIFFERENTIATION, AND APOPTOSIS OF PRIMARY NEOPLASTIC MYELOID CELLS
Authors: GORE SD SAMID D WENG LJ
Citation: Sd. Gore et al., IMPACT OF THE PUTATIVE DIFFERENTIATING AGENTS SODIUM PHENYLBUTYRATE AND SODIUM PHENYLACETATE ON PROLIFERATION, DIFFERENTIATION, AND APOPTOSIS OF PRIMARY NEOPLASTIC MYELOID CELLS, Clinical cancer research, 3(10), 1997, pp. 1755-1762
MODULATION OF RADIATION RESPONSE OF HUMAN TUMOR-CELLS BY THE DIFFERENTIATION INDUCERS, PHENYLACETATE AND PHENYLBUTYRATE
Authors: MILLER AC WHITTAKER T THIBAULT A SAMID D
Citation: Ac. Miller et al., MODULATION OF RADIATION RESPONSE OF HUMAN TUMOR-CELLS BY THE DIFFERENTIATION INDUCERS, PHENYLACETATE AND PHENYLBUTYRATE, International journal of radiation biology, 72(2), 1997, pp. 211-218
VULNERABILITY OF MULTIDRUG-RESISTANT TUMOR-CELLS TO THE AROMATIC FATTY-ACIDS PHENYLACETATE AND PHENYLBUTYRATE
Authors: SHACK S MILLER A LIU L PRASANNA P THIBAULT A SAMID D
Citation: S. Shack et al., VULNERABILITY OF MULTIDRUG-RESISTANT TUMOR-CELLS TO THE AROMATIC FATTY-ACIDS PHENYLACETATE AND PHENYLBUTYRATE, Clinical cancer research, 2(5), 1996, pp. 865-872
PHASE-I STUDY OF LOVASTATIN, AN INHIBITOR OF THE MEVALONATE PATHWAY, IN PATIENTS WITH CANCER
Authors: THIBAULT A SAMID D TOMPKINS AC FIGG WD COOPER MR HOHL RJ TREPEL J LIANG B PATRONAS N VENZON DJ REED E MYERS CE
Citation: A. Thibault et al., PHASE-I STUDY OF LOVASTATIN, AN INHIBITOR OF THE MEVALONATE PATHWAY, IN PATIENTS WITH CANCER, Clinical cancer research, 2(3), 1996, pp. 483-491
UP-REGULATION AND FUNCTIONAL-ROLE OF P21(WAF1 CIP1) DURING GROWTH ARREST OF HUMAN BREAST-CARCINOMA MCF-7 CELLS BY PHENYLACETATE/
Authors: GOROSPE M SHACK S GUYTON KZ SAMID D HOLBROOK NJ
Citation: M. Gorospe et al., UP-REGULATION AND FUNCTIONAL-ROLE OF P21(WAF1 CIP1) DURING GROWTH ARREST OF HUMAN BREAST-CARCINOMA MCF-7 CELLS BY PHENYLACETATE/, Cell growth & differentiation, 7(12), 1996, pp. 1609-1615
FUNCTIONAL-ANALYSIS OF THE PROMOTER AND FIRST INTRON OF THE HUMAN LYSYL OXIDASE GENE
Authors: CSISZAR K ENTERSZ I TRACKMAN PC SAMID D BOYD CD
Citation: K. Csiszar et al., FUNCTIONAL-ANALYSIS OF THE PROMOTER AND FIRST INTRON OF THE HUMAN LYSYL OXIDASE GENE, Molecular biology reports, 23(2), 1996, pp. 97-108
THE DIFFERENTIATING AGENT PHENYLACETATE INCREASES PROSTATE-SPECIFIC ANTIGEN PRODUCTION BY PROSTATE-CANCER CELLS
Authors: WALLS R THIBAULT A LIU L WOOD C KOZLOWSKI JM FIGG WD SAMPSON ML ELIN RJ SAMID D
Citation: R. Walls et al., THE DIFFERENTIATING AGENT PHENYLACETATE INCREASES PROSTATE-SPECIFIC ANTIGEN PRODUCTION BY PROSTATE-CANCER CELLS, The Prostate, 29(3), 1996, pp. 177-182
PLASMA-PROTEIN BINDING OF PHENYLACETATE AND PHENYLBUTYRATE, 2 NOVEL ANTINEOPLASTIC AGENTS
Authors: BOUDOULAS S LUSH RM MCCALL NA SAMID D REED E FIGG WD
Citation: S. Boudoulas et al., PLASMA-PROTEIN BINDING OF PHENYLACETATE AND PHENYLBUTYRATE, 2 NOVEL ANTINEOPLASTIC AGENTS, Therapeutic drug monitoring, 18(6), 1996, pp. 714-720
PHENYLACETATE IS AN INHIBITOR OF PROSTATIC GROWTH AND DEVELOPMENT IN ORGAN-CULTURE
Authors: LIPSCHUTZ JH SAMID D CUNHA GR
Citation: Jh. Lipschutz et al., PHENYLACETATE IS AN INHIBITOR OF PROSTATIC GROWTH AND DEVELOPMENT IN ORGAN-CULTURE, The Journal of urology, 155(5), 1996, pp. 1762-1770
LIPID-METABOLISM AS A TARGET FOR BRAIN CANCER-THERAPY - SYNERGISTIC ACTIVITY OF LOVASTATIN AND SODIUM PHENYLACETATE AGAINST HUMAN GLIOMA-CELLS
Authors: PRASANNA P THIBAULT A LIU L SAMID D
Citation: P. Prasanna et al., LIPID-METABOLISM AS A TARGET FOR BRAIN CANCER-THERAPY - SYNERGISTIC ACTIVITY OF LOVASTATIN AND SODIUM PHENYLACETATE AGAINST HUMAN GLIOMA-CELLS, Journal of neurochemistry, 66(2), 1996, pp. 710-716
TRANSCRIPTIONAL UP-REGULATION OF GAMMA-GLOBIN BY PHENYLBUTYRATE AND ANALOGOUS AROMATIC FATTY-ACIDS
Authors: HUDGINS WR FIBACH E SAFAYA S RIEDER RF MILLER AC SAMID D
Citation: Wr. Hudgins et al., TRANSCRIPTIONAL UP-REGULATION OF GAMMA-GLOBIN BY PHENYLBUTYRATE AND ANALOGOUS AROMATIC FATTY-ACIDS, Biochemical pharmacology, 52(8), 1996, pp. 1227-1233
ACTIVATION OF A HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR BY THE ANTITUMOR AGENT PHENYLACETATE AND ITS ANALOGS
Authors: PINEAU T HUDGINS WR LIU L CHEN LC SHER T GONZALEZ FJ SAMID D
Citation: T. Pineau et al., ACTIVATION OF A HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR BY THE ANTITUMOR AGENT PHENYLACETATE AND ITS ANALOGS, Biochemical pharmacology, 52(4), 1996, pp. 659-667
PHENYLACETATE IN CHEMOPREVENTION - IN-VITRO AND IN-VIVO SUPPRESSION OF 5-AZA-2'-DEOXYCYTIDINE-INDUCED CARCINOGENESIS
Authors: PRASANNA P SHACK S WILSON VL SAMID D
Citation: P. Prasanna et al., PHENYLACETATE IN CHEMOPREVENTION - IN-VITRO AND IN-VIVO SUPPRESSION OF 5-AZA-2'-DEOXYCYTIDINE-INDUCED CARCINOGENESIS, Clinical cancer research, 1(8), 1995, pp. 865-871
PHENYLACETATE IS AN INHIBITOR OF UROGENITAL GROWTH AND DEVELOPMENT
Authors: LIPSCHUTZ JH SAMID D CUNHA GR
Citation: Jh. Lipschutz et al., PHENYLACETATE IS AN INHIBITOR OF UROGENITAL GROWTH AND DEVELOPMENT, Journal of the American Society of Nephrology, 6(3), 1995, pp. 701-701
TRANSCRIPTIONAL UP-REGULATION OF TGF-ALPHA BY PHENYLACETATE AND PHENYLBUTYRATE IS ASSOCIATED WITH DIFFERENTIATION OF HUMAN-MELANOMA CELLS
Authors: LIU L HUDGINS WR MILLER AC CHEN LC SAMID D
Citation: L. Liu et al., TRANSCRIPTIONAL UP-REGULATION OF TGF-ALPHA BY PHENYLACETATE AND PHENYLBUTYRATE IS ASSOCIATED WITH DIFFERENTIATION OF HUMAN-MELANOMA CELLS, Cytokine, 7(5), 1995, pp. 449-456
TRANSCRIPTIONAL ACTIVATION OF THE EPSTEIN-BARR-VIRUS LATENCY C PROMOTER AFTER 5-AZACYTIDINE TREATMENT - EVIDENCE THAT DEMETHYLATION AT A SINGLE CPG SITE IS CRUCIAL
Authors: ROBERTSON KD HAYWARD SD LING PD SAMID D AMBINDER RF
Citation: Kd. Robertson et al., TRANSCRIPTIONAL ACTIVATION OF THE EPSTEIN-BARR-VIRUS LATENCY C PROMOTER AFTER 5-AZACYTIDINE TREATMENT - EVIDENCE THAT DEMETHYLATION AT A SINGLE CPG SITE IS CRUCIAL, Molecular and cellular biology, 15(11), 1995, pp. 6150-6159
DISPOSITION OF PHENYLBUTYRATE AND ITS METABOLITES, PHENYLACETATE AND PHENYLACETYLGLUTAMINE
Authors: PISCITELLI SC THIBAULT A FIGG WD TOMPKINS A HEADLEE D LIEBERMANN R SAMID D MYERS CE
Citation: Sc. Piscitelli et al., DISPOSITION OF PHENYLBUTYRATE AND ITS METABOLITES, PHENYLACETATE AND PHENYLACETYLGLUTAMINE, Journal of clinical pharmacology, 35(4), 1995, pp. 368-373
INHIBITION OF PROLIFERATION AND INDUCTION OF DIFFERENTIATION IN MEDULLOBLASTOMA-DERIVED AND ASTROCYTOMA-DERIVED CELL-LINES WITH PHENYLACETATE
Authors: STOCKHAMMER G MANLEY GT JOHNSON R ROSENBLUM MK SAMID D LIEBERMAN FS
Citation: G. Stockhammer et al., INHIBITION OF PROLIFERATION AND INDUCTION OF DIFFERENTIATION IN MEDULLOBLASTOMA-DERIVED AND ASTROCYTOMA-DERIVED CELL-LINES WITH PHENYLACETATE, Journal of neurosurgery, 83(4), 1995, pp. 672-681
INCREASED SUSCEPTIBILITY OF RAS-TRANSFORMED CELLS TO PHENYLACETATE ISASSOCIATED WITH INHIBITION OF P21(RAS) ISOPRENYLATION AND PHENOTYPIC REVERSION
Authors: SHACK S CHEN LC MILLER AC DANESI R SAMID D
Citation: S. Shack et al., INCREASED SUSCEPTIBILITY OF RAS-TRANSFORMED CELLS TO PHENYLACETATE ISASSOCIATED WITH INHIBITION OF P21(RAS) ISOPRENYLATION AND PHENOTYPIC REVERSION, International journal of cancer, 63(1), 1995, pp. 124-129
CINNAMIC ACID - A NATURAL PRODUCT WITH POTENTIAL USE IN CANCER INTERVENTION
Authors: LIU L HUDGINS WR SHACK S YIN MQ SAMID D
Citation: L. Liu et al., CINNAMIC ACID - A NATURAL PRODUCT WITH POTENTIAL USE IN CANCER INTERVENTION, International journal of cancer, 62(3), 1995, pp. 345-350
PHENYLACETATE SYNERGIZES WITH RETINOIC ACID IN INDUCING THE DIFFERENTIATION OF HUMAN NEUROBLASTOMA-CELLS
Authors: SIDELL N WADA R HAN GY CHANG BS SHACK S MOORE T SAMID D
Citation: N. Sidell et al., PHENYLACETATE SYNERGIZES WITH RETINOIC ACID IN INDUCING THE DIFFERENTIATION OF HUMAN NEUROBLASTOMA-CELLS, International journal of cancer, 60(4), 1995, pp. 507-514
TUMOR RESISTANCE TO OXIDATIVE STRESS - ASSOCIATION WITH RAS ONCOGENE EXPRESSION AND REVERSAL BY LOVASTATIN, AN INHIBITOR OF P21RAS ISOPRENYLATION
Authors: MILLER AC SAMID D
Citation: Ac. Miller et D. Samid, TUMOR RESISTANCE TO OXIDATIVE STRESS - ASSOCIATION WITH RAS ONCOGENE EXPRESSION AND REVERSAL BY LOVASTATIN, AN INHIBITOR OF P21RAS ISOPRENYLATION, International journal of cancer, 60(2), 1995, pp. 249-254
PHASE-I STUDY OF PHENYLACETATE ADMINISTERED TWICE-DAILY TO PATIENTS WITH CANCER
Authors: THIBAULT A SAMID D COOPER MR FIGG WD TOMPKINS AC PATRONAS N HEADLEE DJ KOHLER DR VENZON DJ MYERS CE
Citation: A. Thibault et al., PHASE-I STUDY OF PHENYLACETATE ADMINISTERED TWICE-DAILY TO PATIENTS WITH CANCER, Cancer, 75(12), 1995, pp. 2932-2938
CYTOSTATIC ACTIVITY OF PHENYLACETATE AND DERIVATIVES AGAINST TUMOR-CELLS - CORRELATION WITH LIPOPHILICITY AND INHIBITION OF PROTEIN PRENYLATION
Authors: HUDGINS WR SHACK S MYERS CE SAMID D
Citation: Wr. Hudgins et al., CYTOSTATIC ACTIVITY OF PHENYLACETATE AND DERIVATIVES AGAINST TUMOR-CELLS - CORRELATION WITH LIPOPHILICITY AND INHIBITION OF PROTEIN PRENYLATION, Biochemical pharmacology, 50(8), 1995, pp. 1273-1279
Risultati: 1-25 | 26-43